Suk See De Ravin and colleagues applied an ex vivo gene editing approach using the CRISPR - Cas9 platform to chronic granulomatous disease (CGD), a genetic disorder with limited treatment options that leads to life - threatening infections and often requires long - term antibiotics. (sciencedaily.com)